Selected article for: "antiviral inhibitor and RNA polymerase"
Author: McCreary, Erin K; Pogue, Jason M
Title: Coronavirus Disease 2019 Treatment: A Review of Early and Emerging Options
  • Document date: 2020_3_23
    • ID: j0i9ozsz_53
    Snippet: Galidesivir (BCX4430) Nucleoside RNA polymerase inhibitor with reported wide spectrum of antiviral activity, currently in pipeline of Biocryst Pharma and previously evaluated for Ebola and other hemorrhagic fever virus infections......
    Document: Galidesivir (BCX4430) Nucleoside RNA polymerase inhibitor with reported wide spectrum of antiviral activity, currently in pipeline of Biocryst Pharma and previously evaluated for Ebola and other hemorrhagic fever virus infections.

    Search related documents:
    Co phrase search for related documents
    • antiviral activity and hemorrhagic fever virus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
    • antiviral activity and hemorrhagic fever virus infection: 1
    • antiviral activity and polymerase inhibitor: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20
    • antiviral activity and wide spectrum: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
    • antiviral activity wide spectrum and wide spectrum: 1, 2, 3, 4
    • hemorrhagic fever and polymerase inhibitor: 1